Results 11 to 20 of about 30,199 (219)

Synergistic Sealing of the Pleural Space: Combining Thoracoscopic Talc Poudrage and IPC for Malignant Pleural Effusion—A Case Series [PDF]

open access: yesRespirology Case Reports
Management of malignant pleural effusion (MPE) via medical thoracoscopy presents a clinical challenge, particularly when deciding whether to proceed with talc poudrage during the same setting.
Mas Fazlin Mohamad Jailaini   +3 more
doaj   +3 more sources

Incidence of complications from indwelling pleural catheter for pleural effusion: A meta‐analysis [PDF]

open access: yesClinical and Translational Science, 2023
Indwelling pleural catheter (IPC) is widely used in patients with pleural effusion (PE). This meta‐analysis aimed to comprehensively summarize the clinical complication from IPC.
Shuyan Wang   +7 more
doaj   +2 more sources

The benefit of indwelling pleural catheter with ambulatory pneumothorax device and autologous blood patch pleurodesis in lymphangioleiomyomatosis with persistent air leak. [PDF]

open access: yesRespirol Case Rep, 2023
We report a 35‐year‐old woman who presented with dyspnoea and chest pain for 1 week. High‐resolution computed tomography (HRCT) thorax revealed bilateral pneumothoraces with diffuse lung cysts.
Ng BH   +5 more
europepmc   +2 more sources

Indwelling pleural catheter tract metastasis from renal cell carcinoma [PDF]

open access: yesRespirology Case Reports, 2020
This case highlights the importance of recognizing any new soft tissue abnormalities in cancer patients with an indwelling pleural catheter (IPC) or who has had an IPC.
See‐Wei Low, Kenneth K. Sakata
doaj   +2 more sources

Impact of educational videos and user guide on indwelling pleural catheter caregiver training and unplanned healthcare encounters. [PDF]

open access: yesBMJ Open Qual
Background Indwelling pleural catheters (IPCs) are an effective first line option for the management of symptomatic malignant pleural effusions. However, patients with IPCs often require unplanned healthcare encounters (UHEs) due to complications or ...
Young SL   +10 more
europepmc   +2 more sources

Indwelling pleural catheter and successful autopleurodesis of refractory inflammatory lupus effusion [PDF]

open access: yesRespirology Case Reports, 2020
Indwelling pleural catheter (IPC) is a useful tool for refractory malignant pleural effusions (MPEs). It allows palliation by intermittent symptomatic relief of the effusion and improves quality of life.
Boon Hau Ng   +5 more
doaj   +2 more sources

Predicting the survival in patients with malignant pleural effusion undergoing indwelling pleural catheter insertion [PDF]

open access: yesAnnals of Thoracic Medicine, 2020
CONTEXT: Malignant pleural effusion (MPE) is a common comorbid condition in advanced malignancies with variable survival. AIMS: The aim of this study was to predict the survival in patients with MPE undergoing indwelling pleural catheter (IPC) insertion.
Muhammad Junaid Akram   +5 more
doaj   +2 more sources

Management of malignant pleural effusion and ascites by a triple access multi perforated large diameter catheter port system [PDF]

open access: yesWorld Journal of Surgical Oncology, 2008
Background Pleural or peritoneal effusions (ascites) are frequent in terminal stage malignancies. Medical management may be hazardous. Methods A 60-year-old man with metastatic malignant melanoma presented refractory ascites as well as bilateral pleural ...
Hagen Monica E   +6 more
doaj   +2 more sources

Indwelling pleural catheter infection and colonisation: a clinical practice review. [PDF]

open access: yesJ Thorac Dis
Indwelling pleural catheters (IPCs) are used in the management of malignant pleural effusions, but they can become infected in 5.7% of cases. This review aims to provide a summary of the development of IPC infections and their microbiology, diagnosis and
Sethi DK, Webber MA, Mishra EK.
europepmc   +2 more sources

Efficacy of bevacizumab through an indwelling pleural catheter in non-small cell lung cancer patients with symptomatic malignant pleural effusion. [PDF]

open access: yesBMC Pulm Med
Background Several studies have indicated that intrapleural infusion of bevacizumab is an effective treatment for non-small cell lung cancer (NSCLC) with malignant pleural effusion (MPE).
Zeng H   +6 more
europepmc   +2 more sources

Home - About - Disclaimer - Privacy